DevOps Engineer

United Kingdom

Apply with AI Apply

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

HealthcareIndustries

Requirements

Candidates should have 5+ years of experience in DevOps, systems engineering, or software development. A strong background in CI/CD automation and Infrastructure as Code (e.g., Terraform, Ansible, Puppet) is required, along with hands-on experience with AWS or Azure cloud platforms. Proficiency in scripting languages (Python, Ruby, PowerShell, Shell, etc.), solid knowledge of containerization (Docker, Kubernetes) and orchestration tools, and familiarity with networking fundamentals (TCP/IP, DNS, load balancing, VLANs) are also necessary. Experience with monitoring tools (e.g., Dynatrace, Splunk, Grafana, CloudWatch) is expected, and AWS or Azure certifications, knowledge of cybersecurity and DevSecOps practices, proven ability to support large-scale, distributed systems, and experience with system hardening, patch management, and SaaS operations are considered nice-to-haves.

Responsibilities

The DevOps Engineer will design, build, and scale secure and automated platforms, modernize infrastructure, and accelerate delivery through CI/CD. Responsibilities include building and optimizing CI/CD pipelines and environments, implementing Infrastructure as Code (IaC) and automating configuration management, and developing automation for build, release, and deployment processes. They will manage and scale AWS/Azure environments and SaaS operations, plan for capacity changes, optimize data storage schemas, and support application software, systems, and platform services. Additionally, the engineer will monitor services for uptime, performance, and fault resolution, apply “Privacy-by-Design” and “Security-by-Design” principles, and implement backup, restore, and disaster recovery strategies. They will also act as a key liaison between Agile development and infrastructure operations, mentor junior engineers, promote DevOps best practices, and partner with cross-functional teams and third-party vendors.

Skills

CI/CD

Infrastructure as Code

Terraform

Ansible

Puppet

AWS

Azure

Python

Ruby

PowerShell

Shell

Docker

Kubernetes

TCP/IP

DNS

Load Balancing

VLANs

Monitoring

Automation

Configuration Management

SaaS Operations

Backup

Restore

Disaster Recovery

Agile

Clairo

Generates clinical evidence for trials

About Clairo

Clario specializes in generating clinical evidence for medical research by utilizing a comprehensive technology platform. Their services support various types of clinical trials, including decentralized, hybrid, and site-based trials. Clario's approach combines nearly 50 years of experience with a vast network of facilities across nine countries, allowing them to conduct a significant number of clinical trials and regulatory approvals. What sets Clario apart from competitors is their extensive expertise and the ability to provide a wide range of endpoint technologies, which enhances the quality of evidence produced. The company's goal is to empower partners in the healthcare industry to improve patient outcomes through reliable and rich clinical data.

London, United KingdomHeadquarters

1972Year Founded

$29.9MTotal Funding

GROWTH_EQUITY_VCCompany Stage

Biotechnology, HealthcareIndustries

5,001-10,000Employees

Benefits

Competitive and equitable total rewards package

Physical, mental and financial health and wellness

Flexible working approach

Risks

Increased competition from AI-driven platforms like Medable may threaten Clario's market share.

The IPO filing may lead to investor pressure for rapid financial returns, affecting strategy.

AI integration from ArtiQ poses data privacy and compliance risks, especially in the EU.

Differentiation

Clario offers a comprehensive endpoint technology platform for diverse clinical trial models.

The company has nearly 50 years of experience in clinical trial technology solutions.

Clario's global presence includes 30 facilities across North America, Europe, and Asia Pacific.

Upsides

Clario's IPO aims for a valuation of over $10 billion, indicating strong market confidence.

The FDA clearance of SpiroSphere® with wireless ECG enhances Clario's clinical trial capabilities.

Clario's acquisition of ArtiQ boosts its AI capabilities in respiratory clinical trials.

Land your dream remote job 3x faster with AI

Try Jobo Free